Work

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study

Year: 2005

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdi365

Authors: G.K. Dy, A.A. Miller, S.J. Mandrekar, M.-C. Aubry, R.M. Langdon, R.F. Morton, S.E. Schild, J.R. Jett, A.A. Adjei

Institutions: Mayo Clinic, Wake Forest University Health Sciences, Wake Forest University, Missouri Valley Cancer Consortium, Iowa Oncology Research Association, Scottsdale Community College

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G1094409381, G1423238671, G1569511373, G2082142344, G2440672419, G358241105, G42877212, G6109875642, G844520391

OpenAlex ID: W2161125717

FWCI: 7.345

Cites: 41

Cited by: 149

Related to: 10